Guardian Pharmacyrvices Inc Cla Forecast, price target & analysts
Guardian Pharmacyrvices Inc Cla Target price 2026 - Analyst rating & recommendation
Guardian Pharmacyrvices Inc Cla Classifications & Recommendation
Guardian Pharmacyrvices Inc Cla Price Target
| Target Price | $50.49 |
| Price | $42.38 |
| Potential |
19.14%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Guardian Pharmacyrvices Inc Cla 2027 .
The average Guardian Pharmacyrvices Inc Cla target price is $50.49.
This is
19.14%
register free of charge
$52.50
23.88%
register free of charge
$47.47
12.01%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Guardian Pharmacyrvices Inc Cla to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Guardian Pharmacyrvices Inc Cla stock has an average upside potential 2027 of
19.14%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.45 | 1.47 |
| 17.93% | 1.13% | |
| EBITDA Margin | 5.76% | 9.06% |
| 232.13% | 57.41% | |
| Net Margin | 3.40% | 5.50% |
| 137.92% | 61.88% |
8 Analysts have issued a sales forecast Guardian Pharmacyrvices Inc Cla 2026 . The average Guardian Pharmacyrvices Inc Cla sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Guardian Pharmacyrvices Inc Cla EBITDA forecast 2026. The average Guardian Pharmacyrvices Inc Cla EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Guardian Pharmacyrvices Inc Cla Analysts have issued a net profit forecast 2026. The average Guardian Pharmacyrvices Inc Cla net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.78 | 1.27 |
| 144.07% | 62.82% | |
| P/E | 33.31 | |
| EV/Sales | 1.77 |
8 Analysts have issued a Guardian Pharmacyrvices Inc Cla forecast for earnings per share. The average Guardian Pharmacyrvices Inc Cla EPS is
This results in the following potential growth metrics and future valuations:
Guardian Pharmacyrvices Inc Cla...
Current Guardian Pharmacyrvices Inc Cla Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keybanc |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 07 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Keybanc:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 07 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Apr 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
